Hims & Hers Health EBITDA 2020-2025 | HIMS
Hims & Hers Health annual and quarterly EBITDA history from 2020 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Hims & Hers Health EBITDA for the quarter ending March 31, 2025 was $0.065B, a 453.65% increase year-over-year.
- Hims & Hers Health EBITDA for the twelve months ending March 31, 2025 was $0.128B, a 3653.71% decline year-over-year.
- Hims & Hers Health 2024 annual EBITDA was $0.075B, a 391.27% decline from 2023.
- Hims & Hers Health 2023 annual EBITDA was $-0.026B, a 58.05% decline from 2022.
- Hims & Hers Health 2022 annual EBITDA was $-0.061B, a 43.79% decline from 2021.
| Hims & Hers Health Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $75 |
| 2023 | $-26 |
| 2022 | $-61 |
| 2021 | $-109 |
| 2020 | $-13 |
| 2019 | $-74 |
| 2018 | $0 |
| Hims & Hers Health Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-03-31 | $65 |
| 2024-12-31 | $24 |
| 2024-09-30 | $26 |
| 2024-06-30 | $13 |
| 2024-03-31 | $12 |
| 2023-12-31 | $1 |
| 2023-09-30 | $-8 |
| 2023-06-30 | $-8 |
| 2023-03-31 | $-10 |
| 2022-12-31 | $-10 |
| 2022-09-30 | $-18 |
| 2022-06-30 | $-18 |
| 2022-03-31 | $-14 |
| 2021-12-31 | $-20 |
| 2021-09-30 | $-25 |
| 2021-06-30 | $-17 |
| 2021-03-31 | $-48 |
| 2020-12-31 | $-4 |
| 2020-09-30 | $-3 |
| 2020-06-30 | $-1 |
| 2020-03-31 | $-6 |
| 2019-12-31 | |
| 2019-09-30 | $0 |
| 2019-06-30 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $10.991B | $1.477B |
| Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $37.877B | 52.32 |
| Tempus AI (TEM) | United States | $8.988B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.774B | 74.60 |
| IRhythm Technologies (IRTC) | United States | $4.316B | 0.00 |
| Privia Health (PRVA) | United States | $2.756B | 206.54 |
| Enovis (ENOV) | United States | $1.947B | 12.05 |
| Schrodinger (SDGR) | United States | $1.721B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.712B | 0.00 |
| Phreesia (PHR) | United States | $1.426B | 0.00 |
| Omnicell (OMCL) | United States | $1.202B | 21.21 |
| Azenta (AZTA) | United States | $1.162B | 54.08 |
| 10x Genomics (TXG) | United States | $0.991B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.573B | 0.00 |
| Talkspace (TALK) | United States | $0.530B | 157.25 |
| Butterfly Network (BFLY) | United States | $0.527B | 0.00 |
| Veradigm (MDRX) | United States | $0.486B | 0.00 |
| Standard BioTools (LAB) | United States | $0.403B | 0.00 |
| TruBridge (TBRG) | United States | $0.381B | 0.00 |
| Claritev (CTEV) | United States | $0.329B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.286B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.218B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.200B | 0.00 |
| Pulmonx (LUNG) | United States | $0.138B | 0.00 |
| American Well (AMWL) | United States | $0.106B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.095B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.092B | 0.00 |
| CareCloud (CCLD) | United States | $0.091B | 3.45 |
| MDxHealth SA (MDXH) | Belgium | $0.080B | 0.00 |
| 111 (YI) | China | $0.069B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.063B | 0.00 |
| HeartBeam (BEAT) | United States | $0.062B | 0.00 |
| Outset Medical (OM) | United States | $0.041B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.040B | 0.00 |
| Zhongchao (ZCMD) | China | $0.033B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |